Dr Sara Meade is a Consultant Clinical Neuro-Oncologist at University Hospital Birmingham, where she has been serving for over seven years. Graduating with honours in Medicine from the University of Birmingham in 2003, Dr Meade has pursued advanced training and education in oncology. She holds memberships from prestigious institutions such as the Royal College of Physicians and the Royal College of Radiologists.

Dr Meade specialises in neuro-oncology, with particular interests in skull base and pituitary tumours, as well as stereotactic radiotherapy. Her extensive expertise in these areas allows her to provide comprehensive and cutting-edge care to her patients. In addition to her role at University Hospital Birmingham, she has been serving as the Medical Governance Lead at The Harborne Hospital under HCA Healthcare UK since May 2023.

Throughout her career, Dr Meade has been dedicated to advancing patient care and contributing to medical research. Her commitment to excellence in oncology has made her a respected leader in her field. She is known for her compassionate approach and her dedication to improving patient outcomes.

Dr Meade's areas of expertise include the treatment of various neurological cancers, the management of complex tumour cases, and the application of advanced radiotherapy techniques. Her role involves not only direct patient care but also the development of clinical guidelines and protocols to ensure the highest standards of treatment.

In her spare time, Dr Meade is actively involved in medical research and education, contributing to the ongoing advancement of oncology practices. Her dedication to her field and her patients is evident in every aspect of her work.